Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Karyopherin subunit alpha, commonly known as importin-alpha, is a family of adaptor proteins (KPNA1-7) that play a central role in the classical nuclear import pathway of eukaryotic cells. It functions by recognizing and binding to the nuclear localization signal (NLS) of cargo proteins in the cytoplasm, subsequently forming a trimeric complex with importin-beta1 to facilitate translocation through the nuclear pore complex. Beyond its primary role in transport, importin-alpha is involved in critical cellular processes such as mitotic spindle assembly, nuclear envelope formation, and direct gene regulation under stress conditions. In various malignancies, including lung, gastric, and breast cancers, members of this family (particularly KPNA2) are frequently overexpressed and serve as significant biomarkers for poor prognosis. Furthermore, importin-alpha is a vital host factor hijacked by numerous viruses, such as HIV-1, SARS-CoV-2, and Dengue, to transport viral proteins into the nucleus for replication. Therapeutic strategies targeting importin-alpha, using small molecules like ivermectin or peptide inhibitors, aim to block the nuclear entry of oncogenic or viral proteins, though the essential nature of its biological function presents challenges for achieving high selectivity and safety.
Inhibition of the importin-alpha/beta1 nuclear import pathway by binding to the nuclear localization signal (NLS) binding site of importin-alpha, which prevents the formation of the cargo-importin complex and its subsequent translocation into the nucleus.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Karyopherin subunit alpha (KPNA).